Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

FAPI

  • Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
    You have access
    Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
    Justin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, Manuel Weber, Nader Hirmas, Karina Kostbade, Sebastian Bauer, Martin Schuler, Marit Ahrens, Hans-Ulrich Schildhaus, Christoph Rischpler, Hong Grafe, Jens T. Siveke, Ken Herrmann, Wolfgang P. Fendler and Rainer Hamacher
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 727-734; DOI: https://doi.org/10.2967/jnumed.121.262468
  • You have access
    Dual-tracer PET/CT protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
    Katrin S Roth, Conrad-Amadeus Voltin, Lutz van-Heek, Simone Wegen, Klaus Schomaecker, Thomas Fischer, Simone Marnitz, Alexander E. Drzezga and Carsten Kobe
    Journal of Nuclear Medicine April 14, 2022, jnumed.122.263835; DOI: https://doi.org/10.2967/jnumed.122.263835
  • You have access
    FAPI-PET Opens a New Window for Understanding of Immune-Mediated Inflammatory Diseases
    Torsten Kuwert, Christian Schmidkonz, Olaf Prante, Georg Schett and Andreas Ramming
    Journal of Nuclear Medicine April 7, 2022, jnumed.122.263922; DOI: https://doi.org/10.2967/jnumed.122.263922
  • <sup>68</sup>Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the <sup>68</sup>Ga-FAPI PET Prospective Observational Trial
    You have access
    68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
    Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Sebastian Bauer, Uta Dirksen, Fadi Zarrad, Michael Nader, Michal Chodyla, Aleksandar Milosevic, Lale Umutlu, Martin Schuler, Lars Erik Podleska, Hans-Ulrich Schildhaus, Wolfgang P. Fendler and Rainer Hamacher
    Journal of Nuclear Medicine January 1, 2022, 63 (1) 89-95; DOI: https://doi.org/10.2967/jnumed.121.262096
  • You have access
    Head-to-head comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT for evaluation of head and neck squamous cell carcinoma: a single-center exploratory study
    Chetsadaporn Promteangtrong, Dheeratama Siripongsatian, Attapon Jantarato, Anchisa Kunawudhi, Peerapon Kiatkittikul, Sukanya Yaset, Natphimol Boonkawin and Chanisa Chotipanich
    Journal of Nuclear Medicine December 2, 2021, jnumed.121.262831; DOI: https://doi.org/10.2967/jnumed.121.262831
  • You have access
    Pitfalls and common findings in 68Ga-FAPI-PET – A pictorial analysis
    Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
    Journal of Nuclear Medicine October 7, 2021, jnumed.121.262808; DOI: https://doi.org/10.2967/jnumed.121.262808
  • You have access
    The Latest Developments in Imaging of Fibroblast Activation Protein
    Annette Altmann, Uwe Haberkorn and Jens Siveke
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 160-167; DOI: https://doi.org/10.2967/jnumed.120.244806
  • You have access
    The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience
    Stefan A. Koerber, Fabian Staudinger, Clemens Kratochwil, Sebastian Adeberg, Matthias F. Haefner, Guy Ungerechts, Hendrik Rathke, Erik Winter, Thomas Lindner, Mustafa Syed, Irfan A. Bhatti, Klaus Herfarth, Peter L. Choyke, Dirk Jaeger, Uwe Haberkorn, Juergen Debus and Frederik L. Giesel
    Journal of Nuclear Medicine September 1, 2020, 61 (9) 1331-1336; DOI: https://doi.org/10.2967/jnumed.119.237016
  • You have access
    Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
    Catherine Meyer, Magnus Dahlbom, Thomas Lindner, Sebastien Vauclin, Christine Mona, Roger Slavik, Johannes Czernin, Uwe Haberkorn and Jeremie Calais
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1171-1177; DOI: https://doi.org/10.2967/jnumed.119.236786
  • You have access
    Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
    Thomas Langbein, Wolfgang A. Weber and Matthias Eiber
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.118.220566

Pages

  • Next
  • 1
  • 2
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire